PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Preventing truck crashes needs to take ‘dashcam’ approach to driver ‘microsleeps’

Truck drivers unintentionally taking ‘microsleeps’ of a few seconds can cause terrible traffic accidents, but efforts and technologies aiming to prevent the problem have focused mainly on monitoring driver eye activity while missing a host of other ke

2023-06-01
(Press-News.org) Researchers using dashcam footage of real-world collisions involving large trucks to analyze driver and vehicle behavior has found that anti-drowsiness alarms or similar technologies to prevent falling asleep at the wheel need to go beyond a focus on monitoring the drivers’ eyes, and consider other microsleep behaviors including a relaxation of back and neck muscles and abnormal activity of the vehicle itself.

A study reporting the researchers’ findings was published April 13 in the journal Accident Analysis and Prevention.

Traffic accidents involving large trucks in the United States have increased 47 percent according to the National Safety Council, and in 2021, these vehicles were responsible for nine percent of all vehicles involved in fatal crashes. Several studies worldwide have highlighted in particular the severity of collisions related to drowsy driving and their substantial risk of fatality. 

A major risk here comes from what researchers term “microsleeps.” A microsleep is a brief episode of sleep that lasts for just a few seconds and can occur involuntarily during wakefulness. It can lead to impaired cognitive and motor performance, including slower reaction times, decreased attention, and even complete loss of consciousness. Microsleep episodes can have a significant impact on driving performance and increase the likelihood of dozing off while driving. In 2022, National Police Agency of Japan announced that falling asleep at the wheel was to be included in the same category of “forward inattention” as distraction, which has been the most frequent cause of fatal traffic accidents in the country for over ten years.

A great deal of research into typical microsleep behaviors has investigated one or more aspects of the problem such as eye closure or changes in pupil diameter. No study has yet performed an analysis that takes a more holistic approach considering multiple aspects of the problem, combining the driver’s eye and mouth movements as well as their entire body and vehicle driving behavior. Most such studies have also only considered driver performance during computer simulations. No research has yet looked at actual collisions of large trucks.

“But in recent years, there has been an explosion in the use of dashcam video recorders,” said Hajime Kumagai, lead author of the paper and a specialist in sleep medicine with the Graduate School of Biomedical and Health Sciences at Hiroshima University. 

“This means that a great many traffic accidents, and their possible relationship to episodes of microsleeping have been recorded. This inspired us to employ dashcam footage to investigate microsleep-related behaviors immediately prior to real-world truck collisions.”

In total, the researchers reviewed 3,120 seconds of video footage from interior and exterior dashcams across 52 cases from truck collisions in Japan that had actually happened. They analysed the footage from one minute before the crash right up until the crash. In each incident, the person at the wheel had been a professional driver, and all crashes occurred on either urban roads or highways.

The footage was visually analyzed in a second-by-second manner to simultaneously evaluate any eye changes and microsleep-related activity including the driver’s actions to try to prevent falling asleep (anti-sleepiness behaviors), behavioral signs of microsleep, and abnormal vehicle behavior.

The researchers concluded that the key signs of microsleep include behaviors suggesting a creeping sleepiness, such as the absence of body movement, relaxation of antigravity muscles (the muscles such as back and neck muscles, as well as calves and quadriceps used to support ourselves against the force of gravity), eyes being half-closed, and closure of the eyes for one second or more.

“Up to now, technologies used to attempt to detect and counter falling asleep at the wheel have focused mainly on monitoring the driver’s eyes,” said Toshiaki Shiomi, a co-author of the study. “What we found means that it is crucial to monitor not just the eyes but also the driver's whole body, as well as vehicle behavior in order to reliably detect microsleep-related activity.”

This should also help in avoiding false alarms by ensuring a clear distinction between microsleep-related and non-microsleep-related behaviors. 

Developing advanced safety systems that can detect and alert drivers of potential microsleep episodes involving a whole-of-body approach combined with monitoring of the vehicle for typical microsleep-related abnormal vehicle maneuvers could be an effective intervention for reducing accidents in the trucking industry.

The team hopes now to support work developing such advanced safety systems. These might include technologies that monitor both the inside and outside of the truck using cameras or other sensors, as well as deployment of algorithms that can analyze such data in real-time to detect signs of sleepiness or fatigue. These systems could then alert drivers with an alarm when they are at risk of falling asleep at the wheel.

##

About Hiroshima University

Since its foundation in 1949, Hiroshima University has striven to become one of the most prominent and comprehensive universities in Japan for the promotion and development of scholarship and education. Consisting of 12 schools for undergraduate level and 5 graduate schools, ranging from natural sciences to humanities and social sciences, the university has grown into one of the most distinguished comprehensive research universities in Japan. English website: https://www.hiroshima-u.ac.jp/en

END


ELSE PRESS RELEASES FROM THIS DATE:

Improving immune checkpoint inhibitors’ anti-tumor response and minimizing side effects

Improving immune checkpoint inhibitors’ anti-tumor response and minimizing side effects
2023-06-01
Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade (ICB) - a novel form of cancer treatment utilizing immune checkpoint inhibitors (ICIs) - and minimizes the associated side effects. They demonstrated that using ICIs to target tumor-positive lymph nodes generates a robust anti-tumor response against both local and systemic metastases. The study was published in the Journal of Experimental and Clinical Cancer Research on June 1, 2023. Our immune system uses “checkpoint proteins” to regulate and control the activity of immune cells. But cancer ...

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

2023-06-01
Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet – is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer – the taxanes paclitaxel and docetaxel. Initial results from a large study that tracked CIPN in more than 1,100 patients treated for breast cancer with a taxane show a pattern of clinically meaningful, persistent sensory and motor symptoms, with patients experiencing more severe symptoms with paclitaxel than with docetaxel. These initial results from the SWOG S1714 clinical trial are being reported in an oral presentation at the 2023 annual ...

DOE announces $46 million for commercial fusion energy development

2023-06-01
WASHINGTON, D.C.—The U.S. Department of Energy (DOE) today announced $46 million in funding to eight companies advancing designs and research and development for fusion power plants, representing a major step in President Biden’s commitment to a pilot-scale demonstration of fusion within a decade. Fusion reactions power the stars, and research is underway to make fusion energy production on Earth possible, providing an abundant, inherently safe, non-carbon-emitting energy source for the planet. This funding from the Milestone-Based ...

More than 1 in 6 unvaccinated people report health effects of COVID two years after confirmed infection

2023-06-01
Around 1 in 6 unvaccinated individuals say they are still experiencing health effects of covid-19 up to two years after infection, finds a study from Switzerland published by The BMJ today. The findings show that 17% of participants did not return to normal health and 18% reported covid-19 related symptoms 24 months after initial infection. Most people who have covid-19 recover soon after the initial phase of the disease, but others experience persistent health problems (known as long covid), which can impact quality of life ...

Improving emergency, critical and operative care in low and middle-income countries

2023-06-01
DALLAS and GENEVA, May 31, 2023 — Global efforts to improve emergency, critical and operative care for universal health coverage and protection from health emergencies were announced at the 76th World Health Assembly in Geneva, Switzerland. With the support of its partners the American Heart Association and the Laerdal Foundation, the World Health Organization (WHO), announced an initiative based on a new acute care resolution that was approved at this year’s World Health Assembly, the decision-making body of WHO. Nearly 30 million deaths are due to emergency conditions each year, contributing to half of global deaths. The acute ...

Huntsman Cancer Institute May research highlights

Huntsman Cancer Institute May research highlights
2023-06-01
Huntsman Cancer Institute research highlights shine the spotlight on new discoveries and cutting-edge cancer research. This past month, researchers found a better treatment practice for patients who have melanoma. They also created a model for adrenocortical carcinoma, a rare cancer that originates in the outer portion of the adrenal gland. Learn more about a new brain cancer medication being fast-tracked for FDA approval and how Huntsman Cancer Institute was selected to conduct clinical trials for cancer patients with HIV. Clinical trial suggests changes to melanoma patient care A study recounting a clinical trial published ...

Postdoctoral research experience gets major boost at Pennington Biomedical

Postdoctoral research experience gets major boost at Pennington Biomedical
2023-06-01
Former Pennington Biomedical Research Center Executive Director Dr. Claude Bouchard and his wife, Monique Chagnon, were celebrated at a luncheon on Tuesday, May 30, for their generous gift to enhance the postdoctoral researcher experience at Pennington Biomedical. As one of the world’s foremost researchers in the genetics of obesity and related diseases, including type 2 diabetes and hypertension, the Bouchard laboratory has trained about 40 postdoctoral researchers throughout his career. “I became very conscious that postdocs are critical to the success of the scientific research enterprise. They work hard, they ...

New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure

New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure
2023-06-01
Amsterdam, June 1, 2023 – Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater proportion of patients ...

Liver dialysis device proved safe and effective for treating severe liver failure

2023-06-01
The first successful in-patient trial of liver dialysis* has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators. The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and was associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care. The next step will be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years. Worldwide, it is estimated that there ...

Xrays reveal ancient secrets about our prehistoric world this World Dinosaur Day

2023-06-01
Researchers are shedding light on our ancient prehistoric world using state-of-the art Xray technology. This World Dinosaur Day, scientists are sharing the bones which lay beneath the Harbury Icthyosau – providing clues to dinosaur anatomy, physiology and evolution. The University's of Warwick’s Centre for Imaging, Metrology and Additive Technologies (CiMAT) group at WMG has employed its cutting-edge equipment to explore the anatomy and biology of the Harbury Icthyosaur, a large marine reptile which lived on the Earth hundreds of millions of years ...

LAST 30 PRESS RELEASES:

Anthropologist documents how women and shepherds historically reduced wildfire risk in Central Italy

Living at higher altitudes in India linked to increased risk of childhood stunting

Scientists discover a new signaling pathway and design a novel drug for liver fibrosis

High-precision blood glucose level prediction achieved by few-molecule reservoir computing

The importance of communicating to the public during a pandemic, and the personal risk it can lead to

Improving health communication to save lives during epidemics

Antimicrobial-resistant hospital infections remain at least 12% above pre-pandemic levels, major US study finds

German study finds antibiotic use in patients hospitalised with COVID-19 appears to have no beneficial effect on clinical outcomes

Targeting specific protein regions offers a new treatment approach in medulloblastoma

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Cardiovascular societies propel plans forward for a new American Board of Cardiovascular Medicine

Hebrew SeniorLife selected for nationwide collaborative to accelerate system-wide spread of age-friendly care for older adults

New tool helps identify babies at high-risk for RSV

Reno/Sparks selected to be part of Urban Heat Mapping Campaign

Advance in the treatment of acute heart failure identified

AGS honors Dr. Rainier P. Soriano with Dennis W. Jahnigen Memorial Award at #AGS24 for proven excellence in geriatrics education

New offshore wind turbines can take away energy from existing ones

Unprecedented research probes the relationship between sleep and memory in napping babies and young children

Job losses help explain increase in drug deaths among Black Americans

Nationwide, 32 local schools win NFL PLAY 60 grants for physical activity

Exposure to noise – even while in the egg – impairs bird development and fitness

Vitamin D availability enhances antitumor microbes in mice

Conservation actions have improved the state of biodiversity worldwide

Corporate emission targets are incompatible with global climate goals

Vitamin D alters mouse gut bacteria to give better cancer immunity

Escape the vapes: scientists call for global shift to curb consumer use of disposable technologies

First-of-its-kind study definitively shows that conservation actions are effective at halting and reversing biodiversity loss

A shortcut for drug discovery

Food in sight? The liver is ready!

Climate change could become the main driver of biodiversity decline by mid-century

[Press-News.org] Preventing truck crashes needs to take ‘dashcam’ approach to driver ‘microsleeps’
Truck drivers unintentionally taking ‘microsleeps’ of a few seconds can cause terrible traffic accidents, but efforts and technologies aiming to prevent the problem have focused mainly on monitoring driver eye activity while missing a host of other ke